Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether MST-188 can reduce the duration of
vaso-occlusive crisis (VOC) in subjects with sickle cell disease. The study will also
evaluate whether MST-188 can reduce the frequency of rehospitalization of subjects due to a
recurrence of VOC. Additionally, this study will compare the development of acute chest
syndrome during VOC in subjects who receive MST-188 to those who do not receive MST-188.